Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
about
Estrogen receptors and their implications in colorectal carcinogenesis.Estrogen receptor beta as target for colorectal cancer preventionFuture perspectives for mTOR inhibitors in renal cell cancer treatment.Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice.
P2860
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@en
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@nl
type
label
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@en
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@nl
prefLabel
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@en
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@nl
P2093
P2860
P1476
Raloxifene and antiestrogenic ...... nd decreasing stem-like cells.
@en
P2093
Altaf Mohammed
Chinthalapally V Rao
Gopal Pathuri
Hariprasad Gali
Laura Biddick
Misty Brewer
Naveena B Janakiram
Stan Lightfoot
Taylor Bryant
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0345
P577
2014-01-15T00:00:00Z